Glycogen metabolism

Glycogen metabolism

Block 1

Block 1

Glycolysis
Citric acid cycle
Electron transport chain and oxidative phosphorylation
Gluconeogenesis
Glycogen metabolism
Pentose phosphate pathway
Physiological changes during exercise
Amino acid metabolism
Nitrogen and urea cycle
Fatty acid synthesis
Fatty acid oxidation
Ketone body metabolism
Cholesterol metabolism
Essential fructosuria
Hereditary fructose intolerance
Galactosemia
Pyruvate dehydrogenase deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Lactose intolerance
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Leukodystrophy
Metachromatic leukodystrophy (NORD)
Krabbe disease
Gaucher disease (NORD)
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Fabry disease (NORD)
Tay-Sachs disease (NORD)
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Cystinosis
Hartnup disease
Alkaptonuria
Ornithine transcarbamylase deficiency
Phenylketonuria (NORD)
Cystinuria (NORD)
Homocystinuria
Maple syrup urine disease
Abetalipoproteinemia
Familial hypercholesterolemia
Hypertriglyceridemia
Hyperlipidemia
Disorders of carbohydrate metabolism: Pathology review
Disorders of fatty acid metabolism: Pathology review
Dyslipidemias: Pathology review
Glycogen storage disorders: Pathology review
Lysosomal storage disorders: Pathology review
Disorders of amino acid metabolism: Pathology review
Carbohydrates and sugars
Fats and lipids
Proteins
Nuclear structure
DNA structure
Transcription of DNA
Translation of mRNA
Gene regulation
Epigenetics
Amino acids and protein folding
Protein structure and synthesis
Nucleotide metabolism
DNA replication
Lac operon
DNA damage and repair
Cell cycle
Mitosis and meiosis
DNA mutations
Lesch-Nyhan syndrome
Orotic aciduria
Adenosine deaminase deficiency
Xeroderma pigmentosum
Li-Fraumeni syndrome
Bloom syndrome
Fanconi anemia
McCune-Albright syndrome
Acute radiation syndrome
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
Inheritance patterns
Independent assortment of genes and linkage
Evolution and natural selection
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Fragile X syndrome
Huntington disease
Myotonic dystrophy
Friedreich ataxia
Turner syndrome
Klinefelter syndrome
Prader-Willi syndrome
Angelman syndrome
Beckwith-Wiedemann syndrome
Cri du chat syndrome
Williams syndrome
Alagille syndrome (NORD)
Achondroplasia
Polycystic kidney disease
Familial adenomatous polyposis
Hereditary spherocytosis
Marfan syndrome
Multiple endocrine neoplasia
Neurofibromatosis
Tuberous sclerosis
von Hippel-Lindau disease
Albinism
Cystic fibrosis
Hemochromatosis
Primary ciliary dyskinesia
Sickle cell disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Wilson disease
Alport syndrome
X-linked agammaglobulinemia
Hemophilia
Muscular dystrophy
Wiskott-Aldrich syndrome
Mitochondrial myopathy
Autosomal trisomies: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Miscellaneous genetic disorders: Pathology review
Cell signaling pathways

Transcript

Watch video only

Glucose is a 6-carbon molecule that’s used to make energy, in the form of adenosine triphosphate, or ATP.

Glucose is such an important energy source, that our body stores excess glucose in skeletal muscle cells and liver cells in the form of glycogen.

Glycogen is basically an enormous molecule or polymer, that’s made up of glucose molecules linked together by glycosidic bonds.

You can think of glycogen having a main chain, and there being multiple branches sprouting off of it.

These branches allow glycogen to be compact and capable of rapid addition and removal of glucose.

It’s a bit like growing a plum tree in a tiny house with a short ceiling.

The short ceiling limits the tree’s vertical growth, but the tree’s able to branch off, so that it can still grow and produce many plums in a tight space.

Now let’s say that you just wrapped up a delicious lunch - you had tacos! Glucose is absorbed from the intestine and our blood sugar goes up. The pancreas responds to high blood sugar by secreting insulin.

Insulin acts on glucose transporters on the cell membrane, which are called GLUTs - and makes them bring more glucose into all the cells in our body.

Inside the cell, an enzyme called hexokinase adds a phosphate group to it’s 6th carbon, creating glucose 6 phosphate.

Then, glucose-6-phosphate is broken down during glycolysis, making ATP as a byproduct.

Over time, ATP levels start to rise and that inhibits certain enzymes in glycolysis.

When that happens, the extra glucose-6 phosphate can be used to make glycogen. And that usually takes place in the liver and muscle cells.

There are four main steps in glycogen synthesis.

First is attaching a uridine diphosphate, or UDP molecule to glucose.

Second, is attaching the glucose part of the UDP-glucose molecule to a glycogen primer called glycogenin, forming a short linear glycogen chain, which serves as a primer.

Third, is adding more glucose molecules to that primer - a bit like forming a conga line.

And fourth, is adding branches to the glycogen molecule.

So starting with step one, to make UDP-glucose, an enzyme called phosphoglucomutase moves the phosphate from the 6th carbon of glucose-6-phosphate to the 1st carbon, creating glucose-1-phosphate.

Next, we’ll need energy - which, uniquely, comes in the form of uridine triphosphate, or UTP.

In the presence of glucose-1-phosphate and UTP, an enzyme called UDP-glucose pyrophosphorylase cuts two phosphate molecules off of UTP, which give the energy necessary to complete this reaction.

So only one phosphate remains attached to uridine, and then glucose-1-phosphate is added to it.

That makes two phosphates. So the resulting molecule is called UDP-glucose.

Once many glucose molecules are converted into UDP-glucose molecules, we’re ready to create glycogen.

An enzyme called glycogen synthase catalyzes the attachment of the glucose part of UDP-glucose to another glucose residue at the end of glycogen branch, forming an alpha 1,4 glycosidic bond. It’s almost as if the glucose molecules are holding hands!

And in addition to prolonging the glycogen chain, there’s another byproduct of this reaction is UDP.

But, it turns out that glycogen synthase can only elongate an already existing glycogen chain that’s at least 4 glucose molecules long.

So, if there aren’t at least four glucose molecules linked up together already, then glycogen synthesis requires a protein called glycogenin.

Glycogenin plays the role of fooling glycogen synthase by catalyzing the attachment of 4 glucoses to itself, creating a short chain connected with alpha 1,4 glycosidic bonds.

By doing that, it’s able to tell glycogen synthase “Hey, we have a chain here that kind of looks like an old glycogen molecule”.

Glycogen synthase falls for it, and elongates this short chain on glycogenin by attaching lots of glucose molecules to it through alpha 1,4 glycosidic bonds. This elongates the chain and creates a new linear glycogen molecule.

Key Takeaways

Glucagon is a hormone that helps your body to break down glycogen (a type of sugar) in the liver to release glucose into the bloodstream. This can help to raise blood sugar levels when they are too low, like during fasting. Glucagon is produced by alpha cells of the islets of Langerhans in the pancreas.